Journal of Medicinal Chemistry · 2011 · 10 citations · 22 references
PharmacyMedicinal ChemistryPharmacologyDrug DiscoveryProdrug DesignSynthetic Medicinal ChemistryLipid ChemistryLipid MetabolismTriacylglycerol MetabolismBiological Evaluation ReportIn Vivo StudiesLipidic ProdrugsLipophilic ProdrugsOral ProdrugsProdrug Lipophilicity Optimization
A series of novel fenofibric acid ester prodrugs 1c-1h were synthesized and evaluated with the aim of obtaining potent hypolipidemic agents. Prodrugs 1c and 1d exhibited potent hypochlolesterolemic activity, lowering the mice plasma triglyceride level up to 47% in Swiss albino mice after oral administration of 50 mg/kg/day for 8 days. Fenofibric acid ester prodrugs 1c-1h were found lipophilic like fenofibrate (1b), indicated by partition coefficients measured in octanol-buffer system at pH 7.4. On the basis of in vivo studies, prodrugs 1c and 1d emerged as potent hypolipidemic agents.
22
Hanna E. Bloomfield, Sander J. Robins, Dorothea Collins et al. · New England Journal of Medicine · 1999 · 3.5K citations · Full text
Alazar N. Ghebremeskel, Chandra Vemavarapu, Mayur Lodaya · International Journal of Pharmaceutics · 2006 · 318 citations